Connect with us

Hi, what are you looking for?

Tuesday, Feb 20, 2024
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.


Aphria Inc (TSX:APHA) to Shareholders: Reject Green Growth’s Bid

In what should come as no surprise, Aphria Inc (TSX:APHA)(NYSE:APHA) formally responded to and rejected a takeover bid by U.S. cannabis company Green Growth Brands Inc. (CSE:GGB) (GGBXF). Here’s what they had to say.

In what should come as no surprise, Aphria Inc (TSX:APHA)(NYSE:APHA) formally responded to and rejected a takeover bid by U.S. cannabis company Green Growth Brands Inc. (CSE:GGB) (GGBXF).  The all-stock deal involved an exchange of shares under which Aphria investors would receive 1.5714 shares of Green Growth’s stock. And especially given the recent climb the stock has been on, rising around 80% since the start of the year, it seems like a forgone conclusion that shareholders would outright reject the proposed deal.

It’s important to note that shareholders have not voted on the deal, only that The Company’s board have issued guidance on the matter.

As of Tuesday’s close, Green Growth’s stock was only $5.87, nowhere near the $14.02 that Aphria was trading at. Even at two shares of Green Growth’s stock, it wouldn’t be near fair value.

However, as if price wasn’t enough of a reason, Aphria pulled no punches, stating that the hostile bid:

Although harsh, it’s not unwarranted criticism for a company that I had a hard time believing would think Aphria shareholders would have taken the deal in the first place. Aphria was in the midst of a big selloff and unless investors believed that the stock was headed nowhere but down, there’s little reason to have expected that offer would have garnered any serious consideration.

Moving to the CSE would have big consequences

As Aphria’s Board notes in the release, one of big consequences of taking the bid would be delisting from the TSX and NYSE. It would be a backwards move any way you look at it. Over the past year, we’ve seen many cannabis companies look to list on the major U.S. exchanges, and to throw that away for a fairly unproven company would simply be mind boggling. With a much smaller pool of investors on the Canadian Securities Exchange, it would also hurt Aphria’s ability to raise capital which could have a devastating impact on its ability to achieve significant growth.

Still waiting for a partner

The deal with Green Growth is not likely to go through, but it’s likely Aphria is still looking for a company from another industry to partner up with. Many cannabis stocks have already secured deals with some big names in other industries, including Constellation BrandsMolson Coors Canada, and Altria. The latter, was rumoured to be in talks with Aphria only to eventually invest in Cronos Group Inc.

With the edibles market in Canada expected to be legalized later this year, it’s going to be paramount for Aphria to find a company that has experience in the industry or that has deep pockets that can help fund the growth. The danger for Aphria is falling behind and going at it alone while its peers have a leg up. Overall, I’d be surprised if Aphria doesn’t have a big deal to announce over the next few months.



  1. folorentorium

    February 12, 2019 at 8:01 pm

    I haven¦t checked in here for a while since I thought it was getting boring, but the last few posts are good quality so I guess I will add you back to my daily bloglist. You deserve it my friend 🙂

  2. Romeo Schweinsberg

    February 14, 2019 at 4:14 pm

    You are a very bright person!

  3. Genia Kakowski

    March 10, 2019 at 2:12 pm

    Super info it is actually. My friend has been seeking for this information.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like


Avicanna will be introducing a new medical cannabis care platform website focusing on patient education


Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) has updated its legal team by adding a new chief legal officer who used to hold the...


The firm's fortunes continued to dwindle under the CPG expert's leadership


The firm's annual losses reached US$396.1 million